Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
Cancer - Press Review (May 18, 2013) – Revue de presse (18 mai 2013)
1 view
Skip to first unread message
SMW
May 20, 2013, 6:18:08 AM5/20/13
to
Cancer – Press Review – Revue de Presse
Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com
Press Review (May 18, 2013) – Revue de presse (18 mai 2013)
Washington: Cancer Patients More Prone to Bankruptcy
A study of cancer patients in Washington State has found they were
twice as likely to file for bankruptcy as people without cancer. The
study, led by researchers from the Fred Hutchinson Cancer Research
Center in Seattle, linked bankruptcy court records and information
from the regional cancer registry on about 200,000 cancer patients,
and compared them with a similar group of people from the same area
who did not have cancer. Young people with cancer experienced the
highest bankruptcy rates, the study found, up to 10 times the rate of
bankruptcy filings among older age groups.
By Sabrina Tavernise. In The New York Times
http://www.nytimes.com/2013/05/16/us/washington-cancer-patients-more-prone-to-bankruptcy.html?_r=0
Seeking Calm on the Cancer Ward
When people choose to have their leukemia treated aggressively, it’s a
big commitment, more so than for almost any other cancer.
With this therapy — three days of the drug daunorubicin, which comes
in a reddish color so distinctive that one of my patients, a former
chemist, used it in his professional life as a dye for plastics, and
seven days of the drug cytarabine, which is infused continuously over
168 hours — we offer them the chance to be cured of a disease moving
like wildfire with a stiff breeze behind it at the height of drought.
By Mikkael L. Sekkeres. In The New York Times (blog)
http://well.blogs.nytimes.com/2013/05/16/seeking-calm-on-the-cancer-ward/
Melanoma Treatment Harnesses Immune System to Combat Cancer Cells
A study of cancer patients in Washington State has found they were
twice as likely to file for bankruptcy as people without cancer. The
study, led by researchers from the Fred Hutchinson Cancer Research
Center in Seattle, linked bankruptcy court records and information
from the regional cancer registry on about 200,000 cancer patients,
and compared them with a similar group of people from the same area
who did not have cancer. Young people with cancer experienced the
highest bankruptcy rates, the study found, up to 10 times the rate of
bankruptcy filings among older age groups.
By Andrew Pollock. In The New York Times
http://www.nytimes.com/2013/05/16/business/melanoma-treatment-harnesses-immune-system-to-combat-cancer-cells.html
Cancer patients condemn hospital care
Some go hungry, receive the wrong drugs or feel so uncared for they
consider abandoning treatment.
By Denis Campbell. In The Guardian
http://www.guardian.co.uk/society/2013/may/16/cancer-patients-condemn-hospital-care
Cancer genetics in music and film
“Decoding Annie Parker,” which premiered in New York last month, is
coming to Seattle June 6 and 8 through SIFF. “In this amazing true
story, the lives of cancer-stricken Annie Parker and UW geneticist
Mary-Claire King intertwine, leading to the world-changing discovery
of the BRCA1 breast cancer gene.” Helen Hunt plays King, and Samantha
Morton plays Parker, who now speaks around the world about her
experiences.
By Carol M. Ostrom. In The Seattle Times
http://seattletimes.com/html/localnews/2020989654_doublemastectomyboxxml.html
Cancer du sein : le coup de pouce de Jolie au vendeur de tests
génétiques
En annonçant sa mastectomie préventive, Angelina Jolie a, malgré elle,
fait un cadeau à une société controversée outre-Atlantique : l’action
de Myriad Genetics, le fabricant du test de dépistage, a grimpé de 4%
sur une seule journée. Mais Myriad est poursuivie par des défenseurs
des libertés civiles et des scientifiques pour avoir voulu breveter le
vivant.
Par Sophie Caillat. Dans Rue89
http://www.rue89.com/2013/05/15/cancer-sein-coup-pouce-jolie-vendeur-tests-genetiques-242353
Cancer du poumon : une prise de sang pour repérer les anomalies
génétiques
Une équipe de chercheurs français a mis au point une technique qui
permettrait, à l’aide d’une simple prise de sang, d'identifier les
patients susceptibles de bénéficier d'un traitement ciblé contre le
cancer du poumon
Par Emmanuel Perrin. Dans MaxiSciences
http://www.maxisciences.com/cancer-du-poumon/cancer-du-poumon-une-prise-de-sang-pour-reperer-les-anomalies-genetiques_art29532.html
Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com
Marc Lacroix-Corman – InTextoResearch – Baelen (05/2013)
Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com
Press Review (May 18, 2013) – Revue de presse (18 mai 2013)
Washington: Cancer Patients More Prone to Bankruptcy
A study of cancer patients in Washington State has found they were
twice as likely to file for bankruptcy as people without cancer. The
study, led by researchers from the Fred Hutchinson Cancer Research
Center in Seattle, linked bankruptcy court records and information
from the regional cancer registry on about 200,000 cancer patients,
and compared them with a similar group of people from the same area
who did not have cancer. Young people with cancer experienced the
highest bankruptcy rates, the study found, up to 10 times the rate of
bankruptcy filings among older age groups.
By Sabrina Tavernise. In The New York Times
http://www.nytimes.com/2013/05/16/us/washington-cancer-patients-more-prone-to-bankruptcy.html?_r=0
Seeking Calm on the Cancer Ward
When people choose to have their leukemia treated aggressively, it’s a
big commitment, more so than for almost any other cancer.
With this therapy — three days of the drug daunorubicin, which comes
in a reddish color so distinctive that one of my patients, a former
chemist, used it in his professional life as a dye for plastics, and
seven days of the drug cytarabine, which is infused continuously over
168 hours — we offer them the chance to be cured of a disease moving
like wildfire with a stiff breeze behind it at the height of drought.
By Mikkael L. Sekkeres. In The New York Times (blog)
http://well.blogs.nytimes.com/2013/05/16/seeking-calm-on-the-cancer-ward/
Melanoma Treatment Harnesses Immune System to Combat Cancer Cells
A study of cancer patients in Washington State has found they were
twice as likely to file for bankruptcy as people without cancer. The
study, led by researchers from the Fred Hutchinson Cancer Research
Center in Seattle, linked bankruptcy court records and information
from the regional cancer registry on about 200,000 cancer patients,
and compared them with a similar group of people from the same area
who did not have cancer. Young people with cancer experienced the
highest bankruptcy rates, the study found, up to 10 times the rate of
bankruptcy filings among older age groups.
By Andrew Pollock. In The New York Times
http://www.nytimes.com/2013/05/16/business/melanoma-treatment-harnesses-immune-system-to-combat-cancer-cells.html
Cancer patients condemn hospital care
Some go hungry, receive the wrong drugs or feel so uncared for they
consider abandoning treatment.
By Denis Campbell. In The Guardian
http://www.guardian.co.uk/society/2013/may/16/cancer-patients-condemn-hospital-care
Cancer genetics in music and film
“Decoding Annie Parker,” which premiered in New York last month, is
coming to Seattle June 6 and 8 through SIFF. “In this amazing true
story, the lives of cancer-stricken Annie Parker and UW geneticist
Mary-Claire King intertwine, leading to the world-changing discovery
of the BRCA1 breast cancer gene.” Helen Hunt plays King, and Samantha
Morton plays Parker, who now speaks around the world about her
experiences.
By Carol M. Ostrom. In The Seattle Times
http://seattletimes.com/html/localnews/2020989654_doublemastectomyboxxml.html
Cancer du sein : le coup de pouce de Jolie au vendeur de tests
génétiques
En annonçant sa mastectomie préventive, Angelina Jolie a, malgré elle,
fait un cadeau à une société controversée outre-Atlantique : l’action
de Myriad Genetics, le fabricant du test de dépistage, a grimpé de 4%
sur une seule journée. Mais Myriad est poursuivie par des défenseurs
des libertés civiles et des scientifiques pour avoir voulu breveter le
vivant.
Par Sophie Caillat. Dans Rue89
http://www.rue89.com/2013/05/15/cancer-sein-coup-pouce-jolie-vendeur-tests-genetiques-242353
Cancer du poumon : une prise de sang pour repérer les anomalies
génétiques
Une équipe de chercheurs français a mis au point une technique qui
permettrait, à l’aide d’une simple prise de sang, d'identifier les
patients susceptibles de bénéficier d'un traitement ciblé contre le
cancer du poumon
Par Emmanuel Perrin. Dans MaxiSciences
http://www.maxisciences.com/cancer-du-poumon/cancer-du-poumon-une-prise-de-sang-pour-reperer-les-anomalies-genetiques_art29532.html
Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com
Marc Lacroix-Corman – InTextoResearch – Baelen (05/2013)
0 new messages